StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.57−0.33 (-4.78%)

Close on Nov 17, 2026Market cap $304.70MP/E –Yield –

MapLight Therapeutics total assets

Total assets on the balance sheet at the end of each period.

MapLight Therapeutics's total assets was $368.35M at Jun 30, 2026. For fiscal 2025 it was $479.51M, up 250.2% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$479.51M+250.2%
FY2024Dec 31, 2024$136.92M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$368.35M+169.0%
Q1 FY2026Mar 31, 2026$418.79M–
Q4 FY2025Dec 31, 2025$479.51M–
Q3 FY2025Sep 30, 2025$257.22M–
Q4 FY2024Dec 31, 2024$136.92M–

More MapLight Therapeutics figures

See a number that looks wrong?